PRDM8 exhibits antitumor activities toward hepatocellular carcinoma by targeting NAP1L1

被引:40
作者
Chen, Zhiqiang [1 ,2 ]
Gao, Wen [3 ]
Pu, Liyong [1 ,2 ]
Zhang, Long [1 ,2 ]
Han, Guoyong [1 ,2 ]
Zuo, Xueliang [1 ,2 ]
Zhang, Yao [1 ,2 ]
Li, Xiangcheng [1 ,2 ]
Shen, Hongbing [4 ,5 ]
Wu, Jindao [1 ,2 ,4 ]
Wang, Xuehao [1 ,2 ]
机构
[1] Nanjing Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China
[2] Natl Hlth & Family Planning Commiss, Key Lab Living Donor Liver Transplantat, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[4] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Dept Epidemiol & Biostat,Sch Publ Hlth, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
DNA METHYLATION; EXPRESSION; DIFFERENTIATION; PATHWAY; FAMILY; GENES;
D O I
10.1002/hep.29890
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a major leading cause of cancer mortality worldwide. PRDI-BF1 and RIZ homology domain containing 8 (PRDM8) is a key regulator in neural development and testis steroidogenesis; however, its role in liver carcinogenesis remains to be investigated. In this study, PRDM8 was found to be down-regulated in HCC, which was linked with shorter recurrence-free survival. Lentiviral-based overexpression and knockdown approaches showed that PRDM8 inhibited HCC cell proliferation, migration, and invasion. PRDM8 caused G1/S cell cycle arrest and induced apoptosis. An in vivo tumor model confirmed the antitumor role of PRDM8 in HCC growth and metastasis. Mechanistic study showed that PRDM8 suppressed the PI3K/AKT/mTOR signaling cascade through the regulation of nucleosome assembly protein 1-like 1 (NAP1L1). Conclusion: PRDM8 as a functional tumor suppressor is frequently down-regulated in HCC. Through regulating NAP1L1, PRDM8 inhibits PI3K/AKT/mTOR signaling in HCC. PRDM8 is a potential target for therapies of HCC. (Hepatology 2018).
引用
收藏
页码:994 / 1009
页数:16
相关论文
共 48 条
[1]   Constitutive Canonical NF-κB Activation Cooperates with Disruption of BLIMP1 in the Pathogenesis of Activated B Cell-like Diffuse Large Cell Lymphoma [J].
Calado, Dinis Pedro ;
Zhang, Baochun ;
Srinivasan, Lakshmi ;
Sasaki, Yoshiteru ;
Seagal, Jane ;
Unitt, Christine ;
Rodig, Scott ;
Kutok, Jeffery ;
Tarakhovsky, Alexander ;
Schmidt-Supprian, Marc ;
Rajewsky, Klaus .
CANCER CELL, 2010, 18 (06) :580-589
[2]   Hepatitis C Virus NS5A Targets Nucleosome Assembly Protein NAP1L1 To Control the Innate Cellular Response [J].
Cevik, Recep Emrah ;
Cesarec, Mia ;
Filipe, Ana Da Silva ;
Licastro, Danilo ;
McLauchlan, John ;
Marcello, Alessandro .
JOURNAL OF VIROLOGY, 2017, 91 (18)
[3]   Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis [J].
Chadwick, RB ;
Jiang, CL ;
Bennington, GA ;
Yuan, B ;
Johnson, CK ;
Stevens, MW ;
Niemann, TH ;
Peltomaki, P ;
Huang, S ;
de la Chapelle, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2662-2667
[4]   DNA methylation and carcinogenesis of PRDM5 in cervical cancer [J].
Cheng, Hai-Yan ;
Chen, Xiu-Wei ;
Cheng, Li ;
Liu, Yun-Duo ;
Lou, Ge .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (12) :1821-1825
[5]   PRDM5 is silenced in human cancers and has growth suppressive activities [J].
Deng, QD ;
Huang, S .
ONCOGENE, 2004, 23 (28) :4903-4910
[6]   Histone methyltransferase PRDM8 regulates mouse testis steroidogenesis [J].
Eom, Gwang Hyeon ;
Kim, Kabsun ;
Kim, Sung-Mi ;
Kee, Hae Jin ;
Kim, Ji-Young ;
Jin, Hye Mi ;
Kim, Ju-Ryoung ;
Kim, Jung Ha ;
Choe, Nakwon ;
Kim, Kee-Beom ;
Lee, Junwon ;
Kook, Hyun ;
Kim, Nacksung ;
Seo, Sang-Beom .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 388 (01) :131-136
[7]   PRDM proteins: Important players in differentiation and disease [J].
Fog, Cathrine K. ;
Galli, Giorgio G. ;
Lund, Anders H. .
BIOESSAYS, 2012, 34 (01) :50-60
[8]   Loss of PRDM11 promotes MYC-driven lymphomagenesis [J].
Fog, Cathrine Kolster ;
Asmar, Fazila ;
Come, Christophe ;
Jensen, Klaus Thorleif ;
Johansen, Jens Vilstrup ;
Kheir, Tony Bou ;
Jacobsen, Linda ;
Friis, Carsten ;
Louw, Alison ;
Rosgaard, Louise ;
Obro, Nina Friesgaard ;
Marquart, Hanne Vibeke ;
Anthonsen, Kristian ;
Braat, Arie Koen ;
van Lohuizen, Maarten ;
Ralfkiaer, Elisabeth ;
Gronbaek, Kirsten ;
Lund, Anders Henrik .
BLOOD, 2015, 125 (08) :1272-1281
[9]   Genome-wide DNA methylation analysis in blood cells from patients with Werner syndrome [J].
Guastafierro, T. ;
Bacalini, M. G. ;
Marcoccia, A. ;
Gentilini, D. ;
Pisoni, S. ;
Di Blasio, A. M. ;
Corsi, A. ;
Franceschi, C. ;
Raimondo, D. ;
Spano, A. ;
Garagnani, P. ;
Bondanini, F. .
CLINICAL EPIGENETICS, 2017, 9
[10]   2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds [J].
Guidi, Francesca ;
Puglia, Michele ;
Gabbiani, Chiara ;
Landini, Ida ;
Gamberi, Tania ;
Fregona, Dolores ;
Cinellu, Maria Agostina ;
Nobili, Stefania ;
Mini, Enrico ;
Bini, Luca ;
Modesti, Pietro Amedeo ;
Modesti, Alessandra ;
Messori, Luigi .
MOLECULAR BIOSYSTEMS, 2012, 8 (04) :985-993